CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors.
| Autor: | Lu, Xue1,2 (AUTHOR), He, Yaowu3 (AUTHOR), Johnston, Rebecca L.1 (AUTHOR), Nanayakarra, Devathri1 (AUTHOR), Sankarasubramanian, Sivanandhini1 (AUTHOR), Lopez, J. Alejandro1,2 (AUTHOR), Friedlander, Michael4 (AUTHOR), Kalimutho, Murugan1 (AUTHOR), Hooper, John D.3 (AUTHOR), Raninga, Prahlad V.1 (AUTHOR) Prahlad.Raninga@qimrberghofer.edu.au, Khanna, Kum Kum1 (AUTHOR) KumKum.Khanna@qimrberghofer.edu.au |
|---|---|
| Zdroj: | Journal of Experimental & Clinical Cancer Research (17569966). 12/21/2022, Vol. 41 Issue 1, p1-17. 17p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|